Importantly, SMAD5 expression was increased both in GC patient tumor samples compared to normal samples, and its expression level is related to poor survival rate of GC patients on GEPIA website (Figure 7(a,Figure 7b)), suggesting SMAD5 is closely related to GC progression. The gene discussed is SMAD5; the disease is gastric cancer.